127 related articles for article (PubMed ID: 37248898)
1. Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
Li D; Yu YY; Hu N; Zhang M; Sun FL; Liu L; Fan LM; Ruan SS; Wang F; Rosa-Neto P
J Alzheimers Dis; 2023; 94(1):393-404. PubMed ID: 37248898
[TBL] [Abstract][Full Text] [Related]
2. A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
Li D; Yu YY; Hu N; Zhang M; Liu L; Fan LM; Ruan SS; Wang F
Front Neurol; 2022; 13():884460. PubMed ID: 35547369
[TBL] [Abstract][Full Text] [Related]
3. Expanded Exploration of the Auditory Naming Test in Patients with Dementia.
Hirsch JA; Cuesta GM; Fonzetti P; Comaty J; Jordan BD; Cirio R; Levin L; Abrahams A; Fry KM
J Alzheimers Dis; 2021; 81(4):1763-1779. PubMed ID: 33998546
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer's dementia and mild cognitive impairment: clinical and biomarker correlates.
Aniwattanapong D; Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Tawankanjanachot I; Chuchuen P; Snabboon T; Carvalho AF; Maes M
Aging Ment Health; 2019 Jul; 23(7):840-850. PubMed ID: 30351202
[TBL] [Abstract][Full Text] [Related]
5. Naming unique entities in the semantic variant of primary progressive aphasia and Alzheimer's disease: Towards a better understanding of the semantic impairment.
Montembeault M; Brambati SM; Joubert S; Boukadi M; Chapleau M; Laforce RJ; Wilson MA; Macoir J; Rouleau I
Neuropsychologia; 2017 Jan; 95():11-20. PubMed ID: 27939367
[TBL] [Abstract][Full Text] [Related]
6. Picture-naming test for a linguistically diverse population with cognitive impairment and dementia.
Paplikar A; Varghese F; Alladi S; Vandana VP; Darshini KJ; Iyer GK; Kandukuri R; Divyaraj G; Sharma M; Dhaliwal RS; Kaul S; Saroja AO; Ghosh A; Sunitha J; Khan AB; Mathew R; Mekala S; Menon R; Nandi R; Narayanan J; Nehra A; Padma MV; Pauranik A; Ramakrishnan S; Sarath L; Shah U; Tripathi M; Sylaja PN; Varma RP; Verma M; Vishwanath Y;
Int J Lang Commun Disord; 2022 Jul; 57(4):881-894. PubMed ID: 35522006
[TBL] [Abstract][Full Text] [Related]
7. Boston Naming Test in Alzheimer's disease.
Williams BW; Mack W; Henderson VW
Neuropsychologia; 1989; 27(8):1073-9. PubMed ID: 2797414
[TBL] [Abstract][Full Text] [Related]
8. Speech and language in progressive nonfluent aphasia compared with early Alzheimer's disease.
Mendez MF; Clark DG; Shapira JS; Cummings JL
Neurology; 2003 Oct; 61(8):1108-13. PubMed ID: 14581673
[TBL] [Abstract][Full Text] [Related]
9. [Validation of the Rapid BAttery of Denomination (BARD) in 382 controls and 1004 patients of a memory clinic].
Croisile B; Astier JL; Beaumont C; Mollion H
Rev Neurol (Paris); 2010; 166(6-7):584-93. PubMed ID: 20226490
[TBL] [Abstract][Full Text] [Related]
10. 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease.
Graviotto HG; Sorbara MG; Rodriguez CMT; Serrano C
Dement Neuropsychol; 2022; 16(2):181-186. PubMed ID: 35720650
[TBL] [Abstract][Full Text] [Related]
11. Neurology of anomia in the semantic variant of primary progressive aphasia.
Mesulam M; Rogalski E; Wieneke C; Cobia D; Rademaker A; Thompson C; Weintraub S
Brain; 2009 Sep; 132(Pt 9):2553-65. PubMed ID: 19506067
[TBL] [Abstract][Full Text] [Related]
12. A Danish adaptation of the Boston Naming Test: preliminary norms for older adults and validity in mild Alzheimer's disease.
Jørgensen K; Johannsen P; Vogel A
Clin Neuropsychol; 2017; 31(sup1):72-87. PubMed ID: 28854839
[TBL] [Abstract][Full Text] [Related]
13. Common and divergent neural correlates of anomia in amnestic and logopenic presentations of Alzheimer's disease.
Leyton CE; Hodges JR; Piguet O; Ballard KJ
Cortex; 2017 Jan; 86():45-54. PubMed ID: 27875715
[TBL] [Abstract][Full Text] [Related]
14. Naming test of the Neuropsychological Assessment Battery: convergent and discriminant validity.
Yochim BP; Kane KD; Mueller AE
Arch Clin Neuropsychol; 2009 Sep; 24(6):575-83. PubMed ID: 19700446
[TBL] [Abstract][Full Text] [Related]
15. Comparing the Boston Naming Test With the Neuropsychological Assessment Battery-Naming Subtest in a Neurodegenerative Disease Clinic Population.
Durant J; Berg JL; Banks SJ; Kaylegian J; Miller JB
Assessment; 2021 Jul; 28(5):1256-1266. PubMed ID: 31516023
[TBL] [Abstract][Full Text] [Related]
16. Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort.
Katsumata Y; Mathews M; Abner EL; Jicha GA; Caban-Holt A; Smith CD; Nelson PT; Kryscio RJ; Schmitt FA; Fardo DW
Dement Geriatr Cogn Disord; 2015; 39(3-4):215-27. PubMed ID: 25613081
[TBL] [Abstract][Full Text] [Related]
17. Auditory naming is impaired in posterior cortical atrophy and early-onset Alzheimer's disease.
Putcha D; Eustace A; Carvalho N; Wong B; Quimby M; Dickerson BC
Front Neurosci; 2024; 18():1342928. PubMed ID: 38327846
[TBL] [Abstract][Full Text] [Related]
18. Development of a short form of the Boston naming test for individuals with aphasia.
del Toro CM; Bislick LP; Comer M; Velozo C; Romero S; Gonzalez Rothi LJ; Kendall DL
J Speech Lang Hear Res; 2011 Aug; 54(4):1089-100. PubMed ID: 21173387
[TBL] [Abstract][Full Text] [Related]
19. Naming is associated with left temporal pole metabolite levels in neurodegenerative diseases.
Rami L; Caprile C; Gómez-Ansón B; Sánchez-Valle R; Monte GC; Bosch B; Molinuevo JL
Dement Geriatr Cogn Disord; 2008; 25(3):212-7. PubMed ID: 18212509
[TBL] [Abstract][Full Text] [Related]
20. Argentinean Psycholinguistic Picture Naming Test in color.
Vivas L; Manoiloff L; Linares N; Fernández Zaionz A; Montero L
Appl Neuropsychol Adult; 2022; 29(4):527-535. PubMed ID: 32584150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
